Analyst Profile

Followed by 116 followers
.
Thomas Smith

Thomas Smith

SVB Securities
Wall Street Analyst
#7,144 out of 8,160 Wall Street Analysts
#21,415 out of 24,427 experts

Success Rate

39%
105 out of 268 transactions made a profit

Average Return

-3.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Thomas Smith's trades since 2017 and holding each position for 1 Year would result in 39.18% of your transactions generating a profit, with an average return of -3.1% per rating.

Stock Rating Distribution

363Ratings
90.63% Buy
9.09% Hold
0.28% Sell
Distribution of Thomas Smith's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
United KingdomUK Market

Best Rating

Stock:
89Bio Inc
(ETNB)
Rating:Buy
Date:May 04, 2022 - Today
Return:+252.40%
The most profitable rating made by Thomas Smith

Thomas Smith's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
AMAG
Amag Pharmaceuticals
Sep 08, 2017
Buy
Initiated
1Ratings
100%
+22.10%
TherapeuticsMD
Sep 08, 2017
Hold
Initiated
$6.00
(34.83% Upside)
1Ratings
0.00%
Puma Biotechnology
Jan 17, 2019
Hold
Initiated
$21.00
(371.91% Upside)
1Ratings
0.00%
~ARRY
Array Biopharma
Jun 18, 2019
Hold
Downgraded
3Ratings
100%
+124.60%
PureTech Health
Aug 08, 2022
Buy
Reiterated
5,717.74p
(1831.67% Upside)
1Ratings
100%
+24.20%
PureTech Health
Aug 25, 2022
Buy
Reiterated
$70.00
(89.70% Upside)
10Ratings
44%
+4.50%
Connect Biopharma Holdings
Oct 04, 2022
Buy
Reiterated
$9.00
(1156.11% Upside)
10Ratings
0%
-64.26%
VectivBio Holding
Oct 13, 2022
Buy
Reiterated
$30.00
(265.07% Upside)
7Ratings
57%
+4.06%
Genfit SA
Oct 19, 2022
Buy
Reiterated
$10.00
(164.55% Upside)
10Ratings
0%
-13.06%
Viking Therapeutics
Oct 26, 2022
Buy
Reiterated
$12.00
(181.69% Upside)
12Ratings
63%
+2.01%
List of latest recommendations made by Thomas Smith. Click to expand and see Thomas Smith's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >